This study aims to uncover a novel function of NR4A3 in the context of BLCA progression, providing new insights into the molecular mechanisms underlying anoikis resistance and identifying potential therapeutic strategies for metastatic BLCA. The gene discussed is NR4A3; the disease is bladder transitional cell carcinoma.